Avalo Therapeutics

Avalo Therapeutics

Biotechnology, 540 Gaither Rd Ste 400, Rockville, Maryland, 20850, United States, 11-50 Employees

avalotx.com

  • twitter
  • LinkedIn

phone no Phone Number: 14*********

Who is AVALO THERAPEUTICS

Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patie...

Read More

map
  • 540 Gaither Rd Ste 400, Rockville, Maryland, 20850, United States Headquarters: 540 Gaither Rd Ste 400, Rockville, Maryland, 20850, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AVALO THERAPEUTICS

Avalo Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Avalo Therapeutics

Answer: Avalo Therapeutics's headquarters are located at 540 Gaither Rd Ste 400, Rockville, Maryland, 20850, United States

Answer: Avalo Therapeutics's phone number is 14*********

Answer: Avalo Therapeutics's official website is https://avalotx.com

Answer: Avalo Therapeutics's revenue is $1 Million to $5 Million

Answer: Avalo Therapeutics's SIC: 2834

Answer: Avalo Therapeutics's NAICS: 325412

Answer: Avalo Therapeutics has 11-50 employees

Answer: Avalo Therapeutics is in Biotechnology

Answer: Avalo Therapeutics contact info: Phone number: 14********* Website: https://avalotx.com

Answer: Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access